September CCDD release CONTENT ERRORS

Thanks Beverly!

Hello
I am sorry to say a couple of errors have been discovered in the September CCDD release.
they include the following (see red text below):
DIN 02368153 Xgeva 120 mg/1.7 mL vial
MP 02368153 Xgeva 204 mg/1.7 mL syringe
NTP 9012954 denosumab 204 mg/1.7 mL syringe

DIN 02210401 dobutamine 250 mg/20 mL (12.5 mg/mL) vial
NTP 9012961 dobutamine 5000 mg/20 mL vial
MP 02210401 dobutamine 5000 mg/20 mL vial

Due to the tornado and impact to the CCDD Health Canada resources we will likely be unable to republish with the CCDD with the content corrected this month. Please stay tuned for confirmation of that decision when Health Canada resources are back to the office.
We will be adding how the CCDD team will respond to the need for content corrections and patches in the next release. A reminder from the InfoScribe pages on terms of use is below.
Licensing and Terms of Use
The Canadian Clinical Drug Data Set is licensed by Health Canada
Disclaimer: No Warranty
The Information is licensed “as is”, and the Information Provider excludes all representations, warranties, obligations, and liabilities, whether express or implied, to the maximum extent permitted by law.

The Information Provider is not liable for any errors or omissions in the Information, and will not under any circumstances be liable for any direct, indirect, special, incidental, consequential, or other loss, injury or damage caused by its use or otherwise arising in connection with this licence or the Information, even if specifically advised of the possibility of such loss, injury or damage.
Health Canada is the federal regulator of therapeutic products and does not provide medical advice on the use of the products identified in this database. For information related to treatment options, choices of medications and their uses, illnesses, side effects or drug interactions, please contact your health care professional. For information on where these products are sold, please contact the individual company directly.
thankyou for your understanding
Beverly and CCDD team.